Name: NYIPLA Second Circuit Moot Court Argument
Start: 2014-07-24T05:00

Why Fish

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Pricing

Legal Project Management

Knowledge Management

eDiscovery

Legal Technology Services

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Appellate

Standard Essential Patents

Chancery & Corporate Governance

Post-Grant

Inter Partes Review

Post-Grant Review

Ex Parte Reexamination

Supplemental Examination

Patent

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Industries

Electrical & Computer Technology

Artificial Intelligence

Digital Health

Digital Media & E-Commerce

Financial, Business & FinTech Services

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Post-Grant Annual Reports

Hosts

Name

Brian D. Coggio

Person title

Of Counsel

NYIPLA Second Circuit Moot Court Argument

Hosts

Annual Conference of the Chinese Antibody Society 2025

Los Angeles Bioscience Ecosystem Summit Week 2025

Can Clinical Trials Negate Patentability for Pharma Inventions?

Munich Appeals Court Reinforces Security-Centric FRAND Framework in SEP Dispute

Key Insights From the UPC’s First SEP Decision

Analyzing SEPs: Strategies to Avoid or Prepare for Litigation

The Outlook for SEPs in 2025: Anti-Suit Injunctions, DOJ Policy, and GenAI

Cross-Border Lessons in Using the Hague Evidence Convention

Federal Circuit: PTE for Reissue Patents Should Be Calculated From Original Patent’s Issue Date

Texas Round-Up: February 2025

Recent Decisions and FTC Challenges Dictate Caution When Listing Patents in the Orange Book

USPTO Rescinds 2022 Guidance on Discretionary Denials